Cantel Medical (Cantel Medical) GF Value : $82.84 (As of May. 06, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-06), Cantel Medical's share price is $80.37. Cantel Medical's GF Value is $82.84. Therefore, Cantel Medical's Price-to-GF-Value for today is 0.97.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Cantel Medical is Data Out of Date, Use Caution.

Cantel Medical (NYSE:CMD) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Cantel Medical's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	80.37	/	82.84
	=	0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantel Medical GF Value Related Terms

Thank you for viewing the detailed overview of Cantel Medical's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantel Medical (Cantel Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424

Website

http://www.cantelmedical.com

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

Executives

Ann E Berman	director	255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann	officer: SVP, General Counsel	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades	director, officer: Chief Executive Officer	281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker	director, 10 percent owner, officer: Chairman	ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman	officer: SVP - CFO	C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner	officer: SVP and CHRO	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone	officer: SVP and Princ. Accounting Ofr	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford	officer: President and COO	40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin	officer: Executive Vice President	150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese	director	849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost	director	JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin	director	C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers	director	TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin	director	399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316